Peer Review reports
From: Clinicopathologic features of TDO2 overexpression in renal cell carcinoma
| Original Submission | ||
|---|---|---|
| 27 Jan 2021 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| 1 Mar 2021 | Reviewed | Reviewer Report |
| 3 Mar 2021 | Reviewed | Reviewer Report |
| 5 Mar 2021 | Reviewed | Reviewer Report - Ashutosh Chauhan |
| 7 Mar 2021 | Reviewed | Reviewer Report |
| 9 Mar 2021 | Reviewed | Reviewer Report |
| 24 Mar 2021 | Author responded | Author comments - Wataru Yasui |
| Resubmission - Version 4 | ||
| 24 Mar 2021 | Submitted | Manuscript version 4 |
| 1 Apr 2021 | Author responded | Author comments - Wataru Yasui |
| Resubmission - Version 5 | ||
| 1 Apr 2021 | Submitted | Manuscript version 5 |
| 11 Apr 2021 | Author responded | Author comments - Wataru Yasui |
| Resubmission - Version 6 | ||
| 11 Apr 2021 | Submitted | Manuscript version 6 |
| 24 Apr 2021 | Reviewed | Reviewer Report |
| 26 Apr 2021 | Reviewed | Reviewer Report |
| 27 Apr 2021 | Reviewed | Reviewer Report - Ashutosh Chauhan |
| 2 May 2021 | Reviewed | Reviewer Report |
| 11 May 2021 | Author responded | Author comments - Wataru Yasui |
| Resubmission - Version 7 | ||
| 11 May 2021 | Submitted | Manuscript version 7 |
| 13 May 2021 | Author responded | Author comments - Wataru Yasui |
| Resubmission - Version 8 | ||
| 13 May 2021 | Submitted | Manuscript version 8 |
| 18 May 2021 | Author responded | Author comments - Wataru Yasui |
| Resubmission - Version 9 | ||
| 18 May 2021 | Submitted | Manuscript version 9 |
| 22 May 2021 | Reviewed | Reviewer Report |
| Resubmission - Version 10 | ||
| Submitted | Manuscript version 10 | |
| Publishing | ||
| 24 May 2021 | Editorially accepted | |
| 26 Jun 2021 | Article published | 10.1186/s12885-021-08477-1 |
You can find further information about peer review here.